Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Research Administration and Dosing Considerations Published research on BPC-157 in animal models has used various administration routes: Intraperitoneal injection: Common in rodent studies but impractical for veterinary application Subcutaneous injection: More relevant to potential veterinary use Intramuscular injection: Studied in some larger animal models Oral administration: Some research suggests oral bioavailability, though data is limited Topical application: Investigated for wound healing applications Dosing in animal studies varies widely (typically reported as g/kg body weight), and optimal dosing for dogs specifically has not been established through controlled veterinary trials
Possible side effects may include: Mild injection-site discomfort Nausea or lightheadedness Temporary fatigue Review your health history, current medications, and any questions before starting treatment
This range extrapolates from effective animal doses using standard interspecies scaling calculations
Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer
At maintenance doses of 1.7-2.4mg, published protocols consume roughly one 5mg vial every 2-3 weeks
